Clinical Trial Update: Investigation of Pharmacokinetics,Safety,and Pharmacodynamics of HSK39297 in Subjects With Hepatic Impairment [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the pharmacokinetics, safety, and pharmacodynamics of the investigational drug HSK39297 in subjects with hepatic impairment related to …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paroxysmal Nocturnal Hemoglobinuria

Drugs mentioned

• HSK39297

Snippet

Sponsor: Haisco Pharmaceutical Group Co., Ltd. | Conditions: Paroxysmal Nocturnal Hemoglobinuria (PNH) | Phase 1 | Status: RECRUITING